U.S. Markets closed

See what the IHS Markit Score report has to say about Supernus Pharmaceuticals Inc.

IHS Markit

Supernus Pharmaceuticals Inc

NASDAQ NMS:SUPN

View full report here!

Summary

  • Bearish sentiment is moderate and declining
  • Economic output for the sector is expanding but at a slower rate

Bearish sentiment

Short interest | Positive

Short interest is moderate for SUPN with between 5 and 10% of shares outstanding currently on loan. However, this was an improvement in sentiment as investors who seek to profit from falling equity prices reduced their short positions on May 13.

Money flow

ETF/Index ownership | Neutral

ETF activity is neutral. The $1.12 billion in inflows that ETFs holding SUPN received over the last one-month is a decline from earlier in the period and among the weakest of the past year.

Economic sentiment

PMI by IHS Markit | Negative

According to the latest IHS Markit Purchasing Managers' Index (PMI) data, output in the Healthcare sector is rising. The rate of growth is weak relative to the trend shown over the past year, however, and is easing.

Credit worthiness

Credit default swap

CDS data is not available for this security.

Please send all inquiries related to the report to score@ihsmarkit.com.

Charts and report PDFs will only be available for 30 days after publishing.

This document has been produced for information purposes only and is not to be relied upon or as construed as investment advice. To the fullest extent permitted by law, IHS Markit disclaims any responsibility or liability, whether in contract, tort (including, without limitation, negligence), equity or otherwise, for any loss or damage arising from any reliance on or the use of this material in any way. Please view the full legal disclaimer and methodology information on pages 2-3 of the full report.